Name: Centhaquine: A new resuscitative agent for haemorrhagic shock
Description: Dr Anil Gulati, of Pharmazz, Inc., has developed centhaquine, aka Lyfaquin®. This drug has shown promising results in clinical trials.

Triggered by severe blood loss, haemorrhagic shock is a type of hypovolemic shock, an often-fatal condition. Treatments are available but haven’t been updated for a long time – there is a need for a new resuscitative agent to help patients survive and recover. Luckily, Dr Anil Gulati, of Pharmazz, Inc., has developed centhaquine, aka Lyfaquin®. This drug has shown very […]